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Abstract
Background Concussion diagnosis is typically made
through clinical examination and supported by perfor-
mance on clinical assessment tools. Performance on com-
monly implemented and emerging assessment tools is
known to vary between administrations, in the absence of
concussion.
Objective To evaluate the test-retest reliability of com-
monly implemented and emerging concussion assessment
tools across a large nationally representative sample of
student-athletes.
Methods Participants (n = 4874) from the Concussion
Assessment, Research, and Education Consortium
completed annual baseline assessments on two or three
occasions. Each assessment included measures of self-re-
ported concussion symptoms, motor control, brief and
extended neurocognitive function, reaction time, oculo-
motor/oculovestibular function, and quality of life. Con-
sistency between years 1 and 2 and 1 and 3 were estimated
using intraclass correlation coefficients or Kappa and effect
sizes (Cohen’s d). Clinical interpretation guidelines were
also generated using confidence intervals to account for
non-normally distributed data.
Results Reliability for the self-reported concussion symp-
toms, motor control, and brief and extended neurocognitive
assessments from year 1 to 2 ranged from 0.30 to 0.72
while effect sizes ranged from 0.01 to 0.28 (i.e., small).
The reliability for these same measures ranged from 0.34 to
0.66 for the year 1–3 interval with effect sizes ranging from
0.05 to 0.42 (i.e., small to less than medium). The year 1–2
reliability for the reaction time, oculomotor/oculovestibular
function, and quality-of-life measures ranged from 0.28 to
0.74 with effect sizes from 0.01 to 0.38 (i.e., small to less
than medium effects).
Conclusions This investigation noted less than optimal
reliability for most common and emerging concussion
assessment tools. Despite this finding, their use is still
necessitated by the absence of a gold standard diagnostic
measure, with the ultimate goal of developing more refined
and sound tools for clinical use. Clinical interpretation
guidelines are provided for the clinician to apply with a
degree of certainty in application.
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Key Points
Understanding normal performance variation on
standard clinical assessments of concussion is vital
to application and interpretation in the clinical
setting.
Commonly implemented concussion assessments do
not meet the necessary threshold at 1- and 2-year
testing intervals.
Change scores are provided to give the clinician a
degree of confidence when interpreting post-injury
results.
1 Introduction
Multiple organizations suggest [1, 2] or endorse [3, 4]
athletes engaging in sports that carry a concussion risk
undergo a baseline evaluation prior to participation, against
which to measure impairments resulting from injury. The
baseline assessment also permits medical professionals
caring for concussed athletes to apply individualized per-
formance metrics when determining if the athlete is con-
cussed and/or when to allow for a return to play. Important
in this process is understanding the foundational psycho-
metric properties of the clinical measures. Test reliability,
the level of stability of a test administered on more than
one occasion, is one such metric that influences clinical
decision making by identifying normal variation within the
test vs. variation attributed to a concussion. Ideally, in the
absence of injury, there should be minimal performance
variation on measures that evaluate stable traits such as
neurocognitive function and motor control. State and trait
variance precludes perfect stability, thus it is critical to
know the degree of normal variation on a measure to
determine clinically meaningful performance changes that
can reliability be attributed to injury. As the concussion
diagnosis can only be made through a clinical examination,
test reliability is of particular importance to the healthcare
provider who does not know the true health status of the
athlete and must rely on clinical measures to assist in the
injury management process.
Within the sports medicine community, there is broad
support for the inclusion of measures of neurocognitive
function, motor control, and athlete-reported symptoms to
be used in conjunction with the clinical examination. In
addition, emerging assessments that evaluate eye tracking,
vestibular-ocular function, reaction time, and quality of life
are beginning to be implemented. Collectively, these
measures are used to support the clinical examination for
concussion [1]. Previous research has evaluated the relia-
bility of each of these with varying results.
A wide range of reliabilities [e.g., intraclass correlation
coefficients (ICCs), Pearson’s r, generalizability coefficient
(G)] have been reported for computer-based neurocognitive
assessments, including the Immediate Post-Concussion
Assessment and Cognitive Test [ImPACT]
(ICC = 0.23–0.88), Automated Neuropsychological
Assessment Metrics (ICC = 0.14–0.86), and the Cogstate
Computerized Cognitive Assessment Tool (CCAT, for-
merly named Axon: ICC = 0.45–0.90) [5]. The Standard-
ized Assessment of Concussion (SAC), a neurocognitive
screening tool, has been reported at r = 0.48 [6], while the
Balance Error Scoring System (BESS), a measure of motor
control, is reported at G = 0.63 among male individuals
and G = 0.60 for female individuals when administered
one time [7]. Similarly, the King-Devick test, a measure of
eye tracking, has been reported at ICC = 0.95 in a colle-
giate athlete sample [8]. Variable test performance can be
associated with a number of factors including sleep [9],
testing environment [10], and the test-retest interval [5].
While useful, each of the aforementioned studies has
analyzed performance from relatively small cohorts and
failed to include athletes from varying sexes, a wide
breadth of sports, or skill levels.
While ICCs give a measure of a specific assessment’s
stability over time, interpreting performance changes rel-
ative to concussion is vital for clinical application. Reliable
change indices (RCIs) place a positive and negative range
around a pre-morbid score based on statistical confidence
[11] and have been calculated for many of the measures
noted above. In the case of concussion, worsening scores
that exceed this range following a head impact are typically
attributed to the concussive injury. Reliable change indices
have been applied to computerized neurocognitive assess-
ments [12], neurocognitive screening [13], motor control
[7], and concussion-related symptoms[14] for clinical
interpretation. While broadly applied in the past, RCIs are
calculated using a bi-directional confidence interval,
although only performance declines are of interest fol-
lowing a suspected injury. In addition, RCIs assume a
normal distribution, which is not always the case with
concussion-related assessments. For example, baseline
symptom reports are often right skewed with a mean close
to zero while SAC performance is left skewed with many
individuals scoring at or near maximum performance.
Therefore, the intent of this investigation is to evaluate data
collected as part of a prospective investigation on the
natural history of concussion from a multi-site consortium
to establish the test-retest reliability and clinical interpre-
tation ranges for a number of accepted and emerging
concussion assessment measures.
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2 Methods
Between 2014 and 2017, the Concussion Assessment,
Research, and Education (CARE) Consortium conducted a
30-site investigation on the 6-month natural history of
concussion. All National Collegiate Athletic Association
university student athletes and all cadets at the participating
military service academies were eligible for participation
and all participants provided written informed consent
following protocol approval by both the institution’s local
institutional review board and the US Army Human
Research Protection Office. This study was completed in
accordance with the Declaration of Helsinki.
The CARE methods have been described in detail
elsewhere [15]. Briefly, at the time of enrollment and fol-
lowing consent, each participant completed a detailed
demographics questionnaire and then completed a baseline
assessment. The assessments were divided into mandatory
(Level A measures) and optional emerging concussion
measures (Level B measures) for each of the following.
Level A domains (assessment name and number of sites
providing data) included: neurocognitive screening (SAC,
n = 29 sites), motor control [BESS, n = 29 sites], symp-
toms [Standardized Concussion Assessment Tool (SCAT)
symptom inventory, n = 29 sites; Brief Symptom Inven-
tory (BSI)-18, n = 29 sites], and neurocognitive function
[ImPACT, n = 25 sites; Computerized Neurocognitive
Software Vital Signs, n = 2 sites; CCAT, n = 1 site].
Level B measures included reaction time [clinical reaction
time (RTclin), n = 3 sites], oculomotor/oculovestibular
function [vestibular/ocular-motor screening (VOMS),
n = 9 sites; King-Devick test, n = 6 sites], and quality of
life [Satisfaction with Life Scale (SWLS), n = 11 sites].
The baseline assessment was completed annually for each
year the participant was eligible for the study and prior to
the competitive season. Time to complete the initial base-
line assessment was 55–60 min and approximately 45 min
each successive year. Each assessment is described in brief
below:
2.1 Level A Measures
• The SAC assesses cognitive status after acute injury.
The SAC has demonstrated validity, reliability, and
sensitivity to concussion [16]. The SAC contains sec-
tions on orientation, immediate memory, concentration,
and delayed recall and takes 5 min to administer [6].
• The BESS is an postural stability measure that can be
implemented on the sideline [17]. The test is admin-
istered in 5 min while the athlete completes three 20-s
stance trials (i.e., double leg, single leg, tandem stance)
on firm and foam surfaces.
• The SCAT symptom inventory is a 22-item list of
symptoms commonly associated with concussions (e.g.,
headache, nausea, fatigue). Each athlete rates the
presence/absence of the symptom on a 0–6 Likert
scale, 0 indicating the symptom is not present and 6
being the most severe [18].
• The BSI-18 is a brief symptom inventory designed with
reliability in mind. The BSI-18 assessment gathers
patient-reported data to help measure psychological
distress in primary care settings and has been shown to
be reliable and valid in a brain injury cohort. The
assessment takes 4 min to complete [19].
• ImPACT is a 25-min test that generates composite
scores quantifying performance in the domains of:
attention span, working memory, sustained and selec-
tive attention time, non-verbal problem solving, and
reaction time [20].
• Computerized Neurocognitive Software Vital Signs is a
25- to 30-min test designed to evaluate a number of
cognitive domains such as verbal memory, visual
memory, and executive functioning, through seven
assessment modules [21].
• Cogstate CCAT is a 15-min test that contains four tasks
asking the participant to respond to virtual playing
cards to generate measures of processing speed,
working memory, attention, and learning [22].
2.2 Level B Measures
• RTclin is a modified stick-drop test where the participant
catches a numbered rod as quickly as possible and drop
distance is converted to speed. The test has been shown
to have moderate-to-high sensitivity in a concussed
athletic population and takes 3 min to administer [23].
• Vestibular Ocular Motor Screen is a rapid evaluation of
vestibular and ocular function. During the evaluation,
the clinician evaluates smooth pursuits, saccades,
convergence, fixating on a stationary object while
moving the head side to side/up and down (vestibular
ocular reflex), and standing while tracking a moving
object by and turning the head and torso fully side to
side (visual motion sensitivity) [24].
• The King-Devick test requires an athlete to read single
digit numbers displayed on cards or an electronic tablet.
After suspected head trauma, the athlete is given the
test and, if the time needed to complete the test is
longer than the baseline test time, the athlete should be
removed from play [8].
• The SWLS is a five-item scale that assesses global life
satisfaction in various age groups [25]. The SWLS
suggests that it is sensitive enough to detect changes in
life satisfaction throughout a clinical intervention [26].
Test-retest reliability from the CARE Consortium 1257
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At the time of this analysis, 23,590 student athletes and
cadets had been enrolled and 8675 completed a baseline
assessment on 2 consecutive years and 872 on 3 consecu-
tive years. Throughout the duration of the study, each
CARE participant participated in his/her sport or training
without interference from the study team and cadets com-
pleted their normal physical and tactical training. In the
event a participant sustained a diagnosed concussion, he/
she was evaluated at five post-injury time points, but was
removed from the data set included in this analysis
(n = 1093). In addition, military service academy cadets
that were not National Collegiate Athletic Association
university-level student athletes were not included in the
analysis (n = 2708), but will be described in a forthcoming
publication. The final dataset included 4874 participants
with variable completion rates for each assessment and
year of the study.
2.3 Data Analysis
Distribution metrics (e.g., mean, median, and quartiles)
were first calculated. Reliability can be calculated in a
number of ways (e.g., ICCs and Kappa). Test-retest relia-
bility was estimated between years 1 and 2 and years 1 and
3 using a two-way mixed-model analysis of variance
(ICC3,1) [27] for consistency between assessments. In place
of ICCs, Kappa was used to calculate test-retest reliability
for the SCAT symptom and symptom severity scores and
VOMS measures. This approach was adopted owing to the
skewed distributions exhibited by these scores. Before
Kappa was estimated, data were categorized as 0, 1, 2,
andC 3 for the symptom score and VOMS measures and 0,
1, 2, 3, andC 4 for severity. Intraclass correlation coeffi-
cients and Kappa are scored on a 0–1.0 scale with higher
scores representing more stable performance. Interpretation
of ICCs and Kappa scores vary in the literature with some
suggesting that scores over 0.75 are representative of good
reliability, while those less than 0.75 reflect moderate-to-
poor reliability [28]. Others have suggested higher scores
are needed in making decisions surrounding concussion
diagnosis and management [29]. Cohen’s d effect sizes
were also calculated to evaluate the magnitude of change
between years 1 and 2 and years 1 and 3. Interpretation was
based on recommendations provided by Cohen [30],
whereby estimates\0.2 are deemed small, 0.5 is a medium
effect, and 0.8 is a large effect.
Intraclass correlation coefficients and other calculations
were not completed when the sample was less than 100 to
ensure appropriate representation of the metrics presented.
This largely occurred in the year 1–3 assessments. Infer-
ential statistics (e.g., t tests) were not employed to evaluate
between-year differences because the large sample size
would likely yield statistical significance in the presence of
clinically meaningless changes.
Last, to provide clinical interpretation guidelines that
did not assume normally distributed data, we applied
nonparametric confidence intervals based on the observed
distributions to estimate the degree of certainty of change
on each assessment rather than estimating the percentiles
(i.e., RCIs) of the distribution under the assumption of
normality. This method is more robust when normality
cannot be assumed because, for large sample sizes, the
empirical distribution converges to the true distribution by
the strong law of large numbers [31]. All calculations were
completed using R Version 3.4.0 statistical software
package (Vienna, Austria).
3 Results
Data analysis included 4874 (41.09% female) university-
level student athletes from 29 National Collegiate Athletic
Association institutions. Participant demographics at the
time of the initial baseline assessment were:
19.2± 1.2 years (age), 178.3± 10.96 cm (height), 78.9± 1
9.1 kg (weight), and 0.4± 0.8 concussions reported prior to
enrollment. The mean time between the first and second
assessment was 316.1± 83.4 days and the first and third
assessments were separated by 627.5± 99.8 days.
Distribution metrics and reliability analysis results for
the Level A SAC, BESS, SCAT (symptom total and
severity), and BSI-18 are presented in Table 1. Level A
neurocognitive measures are presented in Tables 2
(ImPACT and CCAT) and Table 3 (Computerized Neu-
rocognitive Software Vital Signs). Distribution metrics and
reliability analysis results for the optional Level B Clinical
Reaction Time, VOMS, King-Devick test, and SWLS are
presented in Table 4. Baseline performance metrics for the
entire cohort and several sub-cohorts have been presented
elsewhere [32] and are consistent with the data presented
here. Reliability for the Level A assessments from the year
1–2 assessments ranged from 0.30 to 0.72 and the year 1–3
assessments ranged from 0.34 to 0.66 (Table 1). Overall,
the reliability analysis indicated slightly lower consistency
for the year 1–3 assessment compared with the year 1–2.
The year 1–2 reliability for the Level B measures ranged
from 0.28 to 0.74 (Table 4), but only one measure (SWLS)
had a large enough sample to generate reliability for years
1–3. Overall, the ImPACT Visual Motor Speed and King-
Devick test were the only evaluations that neared 0.75,
suggesting good reliability for years 1–2 [28].
Cohen’s d calculations for the Level A measures are
presented in Tables 1, 2, 3. Across all Level A measures,
the year 1–2 assessment yielded effect sizes ranging from
0.01 to 0.28 (i.e., small) and the effect sizes for year 1–3
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were 0.05–42 (i.e., small to less than medium). Effect sizes
for the Level B measures are presented in Table 4. Across
all Level B measures, the year 1–2 assessments yielded
effect sizes ranging from 0.01 to 0.38 (i.e., small to less
than medium effects). The SWLS was again the only Level
B measure that had a large enough sample to generate year
1–3 effect sizes.
The change scores for each assessment, through a range
of confidence intervals, were calculated and presented in
Table 5 (Level A) and Table 6 (Level B). These estimates
provide a degree of certainty to the practitioner when
interpreting change in performance following a suspected
concussion. Last, these same analyses have been completed
individually for male and female participants and are pre-
sented in the Electronic Supplementary Material.
4 Discussion
This investigation sought to establish the test-retest relia-
bility and interpretation guidance for a number of widely
used (Level A) and emerging (Level B) sport concussion
assessments. The 1- and 2-year test intervals were selected
as it is common practice for clinical personnel to evaluate
their student athletes annually or once every 2 years during
a collegiate career. Overall, our analysis indicates that both
the commonly accepted and emerging assessments
demonstrated less than optimal reliability for clinical utility
[29]. Our findings are consistent with previous reports for
the SAC [14], SCAT symptom total and severity [33], BSI-
18 [34], and computer-based neurocognitive assessments
[35–37], although the test-retest interval was shorter than
implemented here. However, they are lower than
Table 1 Measures of central tendency, reliability, and effect sizes for Level A clinical concussion measures
SAC n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 3208 27.25 (2.03) 27 26 29 0.39 (0.36–0.42) 0.07
Year 2 27.39 (1.91) 28 26 29
Year 1 372 27.25 (1.99) 28 26 29 0.34 (0.24–0.42) 0.42
Year 3 28.01 (1.65) 28 27 29
BESS n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 2894 13.15 (6.06) 12 9 17 0.41 (0.38–0.44) 0.28
Year 2 11.50 (5.57) 11 7 14
Year 1 323 11.95 (5.58) 11 8 15 0.42 (0.32–0.50) 0.24
Year 3 10.65 (5.46) 10 7 14
SCAT: total symptoms n Mean (SD) Median 1st quartile 3rd quartile Kappa Cohen’s d
Year 1 4360 0.79 (0.77) 1 0 1 0.40 0.10
Year 2 0.71 (0.74) 1 0 1
Year 1 581 0.72 (0.74) 1 0 1 0.42 0.05
Year 3 0.72 (0.78) 1 0 1
SCAT: symptom severity n Mean (SD) Median 1st quartile 3rd quartile Kappa Cohen’s d
Year 1 4360 0.98 (1.04) 1 0 2 0.41 0.11
Year 2 0.88 (0.98) 1 0 1
Year 1 581 0.86 (0.96) 1 0 1 0.41 0.05
Year 3 0.87 (1.00) 1 0 1
BSI-18 n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 4328 2.67 (4.80) 1 0 3 0.38 (0.35–0.40) 0.13
Year 2 2.09 (4.50) 0 0 2
Year 1 551 2.52 (4.05) 1 0 3 0.51 (0.44–0.57) 0.19
Year 3 1.80 (3.73) 0 0 2
BESS balance error scoring system, BSI brief symptom inventory, ICC intraclass correlation coefficient, SAC standardized assessment of
concussion, SCAT standardized concussion assessment tool, SD standard deviation
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previously reported for the BESS [14], RTclin [38], King-
Devick [8], and VOMS [39]. Reliability analysis of the
SWLS has not been completed previously in a similar
cohort.
Effect sizes (i.e., Cohen’s d) were implemented as
another measure evaluating the change between test
administrations, which ranged from small to less than
medium (Tables 1, 2, 3, 4). Tests demonstrating small to
no effect size have substantial overlap in test performance.
Indeed, small effect sizes (d\0.2) represent a 92% overlap
between assessments, while a medium effect size (d = 0.5)
represents an 80% overlap. As noted in Tables 1, 2, 3, 4
Table 2 Measures of central tendency, reliability, and effect sizes for Level A neurocognitive measures
ImPACT verbal memory n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 3154 87.90 (10.36) 90 81 96 0.50 (0.48–0.53) 0.05
Year 2 88.40 (10.52) 91 82 97
Year 1 505 87.61 (10.78) 90 81 96 0.47 (0.40–0.53) 0.23
Year 3 90.00 (9.93) 93 84 99
ImPACT visual memory n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 3154 78.24 (13.31) 80 70 89 0.58 (0.55–0.60) 0.11
Year 2 79.65 (13.25) 81 72 90
Year 1 505 78.04 (13.36) 80 70 89 0.47 (0.40–0.54) 0.22
Year 3 80.86 (12.84) 82 73 91
ImPACT visual motor speed n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 3154 41.78 (6.47) 42.12 37.17 47.02 0.72 (0.70–0.74) 0.13
Year 2 42.64 (6.42) 43.29 38.2 47.75
Year 1 505 42.11 (6.41) 42.4 37.6 47.08 0.66 (0.61–0.71) 0.22
Year 3 43.47 (5.98) 44.03 39.47 48.22
ImPACT reaction time n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 3149 0.5867 (0.09) 0.57 0.53 0.63 0.47 (0.44–0.50) 0.05
Year 2 0.5828 (0.08) 0.57 0.53 0.62
Year 1 503 0.598 (0.11) 0.57 0.53 0.64 0.34 (0.26–0.42) 0.14
Year 3 0.585 (0.08) 0.58 0.53 0.63
CCAT composite processing speeda n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 447 102.76 (6.11) 103.8 100.1 106.5 0.49 (0.41–0.55) 0.09
Year 2 103.31 (5.86) 104.2 100.9 107
CCAT composite attentiona n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 448 106.39 (4.71) 107 103.8 109.82 0.56 (0.49–0.62) 0.01
Year 2 106.36 (5.24) 106.9 103.3 109.82
CCAT composite learninga n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 446 104.64 (10.25) 103.7 98.2 111.2 0.54 (0.47–0.6) 0.28
Year 2 107.46 (10.12) 107.3 100.73 115.3
CCAT working memory speed: speeda n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 448 103.52 (6.15) 104 99.38 107.8 0.59 (0.53–0.65) 0.15
Year 2 104.47 (6.1) 104.5 100.57 108.5
CCAT computerized concussion assessment tool, ICC intraclass correlation coefficient, ImPACT immediate post-concussion assessment and
cognitive test, SD standard deviation
aIndicates insufficient sample size to complete the year 1–3 estimates
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Table 3 Measures of central tendency, reliability, and effect sizes for Level A neurocognitive measure
CNS neurocognition indexa n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 238 98.36 (10.82) 98.5 93.25 105 0.33 (0.21–0.44) 0.01
Year 2 98.21 (12.71) 100 93 106
CNS composite memory standard scorea n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 238 95.72 (16.3) 96 86 106.75 0.43 (0.32–0.53) 0.07
Year 2 96.89 (17.28) 97 86 108
CNS verbal memory standard scorea n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 238 94.68 (18.1) 97 83 108 0.41 (0.29–0.51) 0.02
Year 2 95.07 (20.17) 97 86 109
CNS visual memory standard scorea n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 238 98.2 (15.1) 98 90 110 0.31 (0.19–0.42) 0.06
Year 2 99.05 (15.46) 101 91 110
CNS psychomotor speed standard scorea n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 239 105.3 (13.54) 106 98 113.5 0.58 (0.49–0.66) 0.06
Year 2 104.5 (13.53) 105 95.5 113
CNS reaction time standard scorea n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 240 97 (16.31) 99 89 108 0.53 (0.43–0.62) 0.02
Year 2 96.77 (14.17) 98 88 107
CNS complex attention standard scorea n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 237 98.14 (14.64) 101 89 110 0.49 (0.39–0.58) 0.05
Year 2 97.39 (16.18) 101 92 107
CNS cognitive flexibility standard scorea n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 240 97.51 (14.15) 98 92 107 0.40 (0.28–0.5) 0.2
Year 2 100.2 (13.22) 102 92 109
CNS processing speed standard scorea n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 240 102.38 (14.8) 101 94 110.25 0.61 (0.52–0.68) 0.04
Year 2 103 (16.16) 102 93 112
CNS executive function standard scorea n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 240 98.57 (13.68) 99 93 107 0.44 (0.33–0.54) 0.26
Year 2 101.88 (11.36) 102.5 94 110
CNS simple attention percentile n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 267 46.63 (26.93) 50 23 70 0.30 (0.19–0.41) 0.13
Year 2 43.29 (26.55) 40 16 70
CNS motor speed standard scorea n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 239 105.13 (12.79) 105 99 112 0.53 (0.44–0.62) 0.11
Year 2 103.87 (10.95) 103 97 110
CNS computerized neurocognitive software, ICC intraclass correlation coefficient, SD standard deviation
aIndicates insufficient sample size to complete the year 1–3 estimates
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Table 4 Measures of central tendency, reliability, and effect sizes for Level B concussion assessments
Clinical reaction timea n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 261 198.26 (22.57) 197 184 213 0.32 (0.21–0.43) 0.34
Year 2 190.61 (22.63) 190 176 206
VOMS smooth pursuita n Mean (SD) Median 1st quartile 3rd quartile Kappa Cohen’s d
Year 1 525 0.34 (1.07) 0 0 0 0.3 0.01
Year 2 0.35 (1.04) 0 0 0
VOMS horizontal saccadesa n Mean (SD) Median 1st quartile 3rd quartile Kappa Cohen’s d
Year 1 525 0.39 (1.12) 0 0 0 0.29 0.01
Year 2 0.4 (1.17) 0 0 0
VOMS vertical saccadesa n Mean (SD) Median 1st quartile 3rd quartile Kappa Cohen’s d
Year 1 524 0.4 (1.17) 0 0 0 0.28 0.02
Year 2 0.42 (1.18) 0 0 0
VOMS near point convergence symptomsa n Mean (SD) Median 1st quartile 3rd quartile Kappa Cohen’s d
Year 1 474 0.45 (1.29) 0 0 0 0.36 0.01
Year 2 0.44 (1.28) 0 0 0
VOMS near point convergence distancea n Mean (SD) Median 1st quartile 3rd quartile Kappa Cohen’s d
Year 1 521 2.16 (2.76) 1 0 3 0.51 0.01
Year 2 2.14 (3.15) 1 0 3
VOMS VOR horizontala n Mean (SD) Median 1st quartile 3rd quartile Kappa Cohen’s d
Year 1 525 0.56 (1.48) 0 0 0 0.38 0.19
Year 2 0.59 (1.44) 0 0 0
VOMS VOR verticala n Mean (SD) Median 1st quartile 3rd quartile Kappa Cohen’s d
Year 1 525 0.52 (1.48) 0 0 0 0.38 0.02
Year 2 0.55 (1.43) 0 0 0
VOMS visual motion sensitivitya n Mean (SD) Median 1st quartile 3rd quartile Kappa Cohen’s d
Year 1 521 0.54 (1.56) 0 0 0 0.35 0.01
Year 2 0.52 (1.43) 0 0 0
King-Devick n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 755 43.78 (7.83) 42.85 38.26 48.44 0.74 (0.70–0.77) 0.38
Year 2 40.90 (7.40) 40.06 35.68 45.49
Satisfaction with life scale n Mean (SD) Median 1st quartile 3rd quartile ICC (lower, upper bound) Cohen’s d
Year 1 966 29.20 (4.86) 30 27 33 0.49 (0.44–0.54) 0.18
Year 2 28.32 (4.92) 29 26 31
Year 1 166 29.50 (4.42) 30 28 32 0.42 (0.28–0.53) 0.21
Year 3 28.51 (4.80) 29 27 31
ICC intraclass correlation coefficient, VOMS vestibular/ocular-motor screening, VOR vestibular ocular reflex, SD standard deviation
aIndicates insufficient sample size to complete the year 1–3 estimates
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Table 5 Confidence ranks by change score for Level A concussion measures
75% 87.5% 90% 92.5% 95% 97.5% 99%
SAC
Years 1–2 - 1 - 2 - 2 - 3 - 3 - 4 - 5
Years 1–3 - 1 - 1 - 2 - 2 - 2.5 - 3 - 4.3
BESS
Years 1–2 2 5 6 7 9 11.7 14
Years 1–3 2 4 5 8 9 13 14
SCAT total
Years 1–2 1 3 3 4 5 7 10
Years 1–3 1 3 4 5 6 8 10.4
SCAT severity
Years 1–2 1 4 6 7 9 15 24
Years 1–3 2 6 7 8 10 15 27.6
BSI-18
Years 1–2 0 2 3 4 6 10 15.7
Years 1–3 0 2 2 3 4.5 7 10
ImPACT verbal memory
Years 1–2 - 5 - 10 - 12 - 14 - 17 - 21 - 27
Years 1–3 - 3 - 9 - 9.6 - 12 - 14 - 18.4 - 23
ImPACT visual memory
Years 1–2 - 6 - 12 - 14 - 16 - 18 - 23 - 28
Years 1–3 - 6 - 12 - 13.6 - 16 - 18 - 23.8 - 28
ImPACT visual motor speed
Years 1–2 - 2.1 - 4.1 - 4.8 - 5.8 - 6.8 - 8.5 - 11.2
Years 1–3 - 1.9 - 3.9 - 4.4 - 5.1 - 5.9 - 7.4 - 9.1
ImPACT reaction time
Years 1–2 0.04 0.07 0.08 0.09 0.12 0.15 0.22
Years 1–3 0.04 0.07 0.08 0.1 0.12 0.15 0.21
CCAT composite processing speeda
Years 1–2 - 2.4 - 5.4 - 6.5 - 7.9 - 9.1 - 12.4 - 15.4
CCAT composite attentiona
Years 1–2 - 2.7 - 4.7 - 5 - 5.5 - 6.9 - 9.6 - 14.7
CCAT composite learninga
Years 1–2 - 3.15 - 7.6 - 9.3 - 11.2 - 14.3 - 16.9 - 21.1
CCAT working memory speed: speeda
Years 1–2 - 2.5 - 5.2 - 6.1 - 7.3 - 8.4 - 10.4 - 13.1
CNS neurocognition indexa
Years 1–2 - 5 - 9 - 10 - 11 - 13.2 - 17 - 58.2
CNS composite memory standard scorea
Years 1–2 - 10 - 18 - 19.6 - 24 - 27.2 - 35.2 - 40.9
CNS verbal memory standard scorea
Years 1–2 - 11 - 20.4 - 25.3 - 27 - 31.2 - 38.2 - 49.4
CNS visual memory standard scorea
Years 1–2 - 10.8 - 19.4 - 22 - 25.2 - 28.5 - 34.3 - 40.9
CNS psychomotor speed standard scorea
Years 1–2 - 8 - 14 - 15 - 16 - 18.1 - 21 - 29
CNS reaction time standard scorea
Years 1–2 - 8 - 15 - 16 - 18 - 22 - 28 - 31.6
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and despite the lower than optimal reliability scores, the
limited range of effect sizes suggests a substantial overlap
between the first- and second-year or first- and third-year
evaluations. This is slightly counter to the calculated ICC
values, but highlights the potential that tightly clustered
values may have skewed the ICCs downward (see below).
Table 5 continued
75% 87.5% 90% 92.5% 95% 97.5% 99%
CNS complex attention standard scorea
Years 1–2 - 9 - 16 - 19.4 - 21 - 25 - 32.1 - 42.8
CNS cognitive flexibility standard scorea
Years 1–2 - 6 - 11 - 13 - 14.1 - 17.1 - 22.1 - 37.1
CNS processing speed standard scorea
Years 1–2 - 7 - 12 - 15.1 - 17 - 21 - 29.1 - 37.8
CNS executive function standard scorea
Years 1–2 - 5 - 9 - 11 - 12 - 15 - 18 - 22.2
CNS simple attention percentile
Years 1–2 - 29 - 39 -41 - 49 - 56 - 73 - 78
CNS motor speed standard scorea
Years 1–2 - 7 - 11 - 13 - 14.2 - 18.1 - 23.1 - 29.2
BESS balance error scoring system, BSI brief symptom inventory, CCAT computerized concussion assessment tool, CNS computerized neu-
rocognitive software, ImPACT immediate post-concussion assessment and cognitive test, SAC standardized assessment of concussion, SCAT
standardized concussion assessment tool
aIndicates insufficient sample size to complete the year 1–3 estimates
Table 6 Confidence ranks by change score for Level B concussion measures
75% 87.50% 90% 92.50% 95% 97.50% 99%
Clinical reaction timea
Years 1–2 10 22 29 31 38 45 53
VOMS smooth pursuita
Years 1–2 0 1 1 1 2 3 4
VOMS horizontal saccadesa
Years 1–2 0 1 1 1 2 3 4.8
VOMS vertical saccadesa
Years 1–2 0 1 1 1 2 3 4
VOMS near point convergence symptomsa
Years 1–2 0 1 1 1 2 3.2 4.3
VOMS near point convergence distancea
Years 1–2 1 2 3 3 4 6 9.8
VOMS VOR horizontala
Years 1–2 0 1 1 2 2 3.9 5
VOMS VOR verticala
Years 1–2 0 1 1 2 2 3.9 5
VOMS visual motion sensitivitya
Years 1–2 0 1 1 2 2 4 4
King-Devick total timea
Years 1–2 0.04 2.3 3.2 4 5.7 7.5 8.9
Satisfaction with life scale
Years 1–2 1 3 4 4 5 8 12
Years 1–3 1 3 4 5 5 7 9
VOMS vestibular/ocular-motor screening, VOR vestibular ocular reflex
aIndicates insufficient sample size to complete the year 1–3 estimates
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In addition, the change in scores, with the exception of the
SWLS, all demonstrated improvement on the assessments,
suggesting a small-to-medium learning effect from years 1
to 2 and 1 to 3.
The differences between our findings and those reported
previously may be explained in part by the large, diverse,
and nationally representative cohort implemented here,
which yielded slightly differing performances on the cho-
sen assessments [32]. For example, performance on the
SAC is consistent with previous findings of a collegiate
cohort [16], but our sample was slower on the clinical
reaction time by 5–15 ms [40] and the King-Devick test by
2–5 s, although the administration modality may have
influenced performance on the latter [41]. Conversely, our
sample performed better on the BESS test by approxi-
mately one error [16] and reported a 1.5 point lower
symptom total and 0.5 point symptom severity score [42].
In addition, when examining reliability across the testing
interval, assessment reliability was approximately the same
between the year 1–2 and 1–3 administrations, although
stability of individual tests fluctuated (Tables 1, 2, 3, 4).
However, other studies have shown higher reliabilities are
associated with shortening the testing interval [5]. The high
degree of overlap between the year 1 and 2 and 1 and 3
performances would therefore suggest that every year or
every other year, repeat baseline testing during the colle-
giate career may not be advantageous to concussion man-
agement, particularly when the cost/benefit trade-off of
annual testing is considered. However, baseline testing
should continue to be implemented, but a single adminis-
tration at the time of college enrollment may suffice across
the academic career. The assessment of the sensitivity and
specificity of these measures alone or in combination using
variable baseline assessment intervals is needed to confirm
this recommendation.
Importantly, the measures included in this investigation
have previously been shown to be the most sensitive to
change following concussion [43, 44], but are largely non-
stable cognitive assessments affected by many factors in
non-injured individuals. Among other conditions common
to collegiate athletes, lack of sleep [45], anxiety [46],
psychiatric disorders [47], or apathy from repeat baseline
testing can all influence test performance to a degree
equivalent to a concussive injury. As such, it is unlikely
that any measure will achieve perfect or near-perfect sta-
bility when the underlying function is not constant over
time with variability in both state and trait function.
Therefore, establishing a range of normal variation on these
measures allows the clinician to consistently identify a
change from baseline performance that is outside normal
variation as clinically meaningful and the result of injury.
To assist in the interpretation of these concussion
assessment tools in the clinical setting, we calculated
change scores with an associated level of certainty (i.e.,
confidence intervals; Tables 5, 6). The scores within each
interval offer an associated level of confidence the clinician
can hold when the post-injury score meets or exceeds that
value. For example, if a SAC score declines by five points,
the clinician can have 99% confidence that the change is
related to something (e.g., concussion) other than normal
test-retest variability. Similarly, a six-point increase in the
SCAT symptom severity would carry 90% confidence.
This approach differs from previous works implementing
differing statistical methods (e.g., reliable change index)
that identified firm thresholds that placed clinically mean-
ingful change into a yes/no dichotomy. However, the
confidence continuum is in line with emerging thought that
concussion is not immediately present at the time of impact
but can evolve over time, leading to variable levels of
diagnostic certainty [48]. Indeed, our approach to concus-
sion assessment interpretation could be overlaid with
clinical features (e.g., signs and symptoms) of the injury to
establish diagnostic certainty in a way that tests exceeding
90% would represent ‘definite’ concussions, those between
50 and 90% are ‘probable’ concussions, and those\50%
are ‘possible’ concussions. To verify this approach and
refine the confidence ranges, future works should apply the
scores from the assessments to both concussed and control
athletes both individually and in unison to establish their
sensitivity and specificity.
Despite lower than acceptable reliability on the majority
of the instruments evaluated here, these assessment tools
are endorsed by a number of organizations [18, 49, 50] and
are broadly implemented in the clinical setting. The reliance
on consensus and clinical experience to implement these
measures is at odds with the reliability metrics presented
herein, but ICCs can be artificially lowered when the vari-
ability among participants is small. That is, when scores are
tightly clustered (see the quartile range in Tables 1, 2, 3, 4)
the ICC calculation can fall to or below zero (i.e., negative
value) or exceed 1.0. This did not occur in our estimates,
indicating all of our scores are valid [28]. Our large sample
size would not have affected our estimates, rather it pro-
vided a stable confidence interval [51]. Despite the limita-
tion in calculating the ICC, this method is still preferred
over a Pearson r, which evaluates the relationship between
measurements, making it unsuitable for this application
[52]. Ultimately, while none of these measures individually
meet the reliability standards set for clinical utility, there is
evidence that combining them in a multifaceted assessment
model provides a high level of sensitivity by comparing
baseline performance to post-concussion changes in cog-
nitive functioning [43, 44, 53]. Future works should eval-
uate the post-concussion sensitivity and specificity of the
measures included herein both alone and in combination to
mitigate concerns surrounding less than optimal reliability.
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This investigation is not without limitation. Perhaps
most notable is the assumption that all student athletes
provided an honest effort during the test administrations.
The computer-based neurocognitive assessments contain
embedded validity checks and if a participant was flagged
as invalid, he/she was asked to repeat the exam an addi-
tional time. A second invalid test did not mandate an
additional assessment, but this was a small number relative
to the entire sample (n = 21). The other assessments do not
have similar validity checks. This is of particular impor-
tance as some athletes may intentionally underperform on a
baseline evaluation in an effort to hide poor post-concus-
sion performance at a later date [54] or the athletes may
become apathetic with multiple years of testing. In addi-
tion, our testing intervals (1 and 2 years) are considerably
longer than the typical time from a baseline assessment to
injury [55], potentially resulting in lower reliability values
[5]. We also note that our participants demonstrated
improvement on some measures, suggesting a learning
effect. Clinicians may consider administering practice tests
to reduce these effects, although we did not evaluate for
this; nor did we ask if the athlete completed these same
measures in the past (e.g., high school athletics). Last,
these findings may not apply to younger athletes who are
continuing to undergo significant brain growth and devel-
opment [56–59] that would warrant annual baseline
assessments [49] or to professional athletes who have likely
completed full brain maturation.
While brain development can vary widely between
individuals, it is well accepted that the adolescent brain
undergoes a period of rapid gray matter production during
the teenage years, particularly in the pre-frontal cortex. The
pre-frontal cortex reaches a peak volume around the age of
12 years, but it is among the last regions of the brain to
achieve full functional maturation in the mid-20 s [56].
The transition from peak volume to peak efficiency is a
result of gray matter pruning that streamlines the most
often used cortical pathways [56]. The influence the
changing cerebral structure has on cognitive performance
has been demonstrated with cross-sectional work showing
an overall age-related difference in test performance with
older athletes performing better than younger athletes [60].
As such, the prospect of a single concussion assessment
baseline in an adolescent population is likely not prudent.
5 Conclusion
In the final analysis, this investigation provides a founda-
tional psychometric evaluation of commonly implemented
concussion assessment tools among collegiate athletes.
None of these measures met or exceeded the accepted
threshold for clinical utility, but ongoing revision and
refinement are recommended over abandoning their use.
Most measures fell well below levels of clinical utility,
although the King-Devick test (years 1–2) and ImPACT-
Visual Motor Speed (years 1–2) approached an accept-
able level. Despite these findings, the overlap between
assessment times was substantial for all measures, despite
fluidity of their underlying constructs. As such, the annual
baselines captured here likely represent state function of
overt traits that will continue to vary with more testing.
Therefore, among collegiate athletes, baseline assessments
beyond the initial evaluation will likely not equate to better
injury management. This raises the question about the
value of annual baseline assessments in collegiate athletes,
as repeat testing may not provide any additional clinical
information beyond the initial evaluation. Despite the
findings presented herein, the sensitivity of these measures
alone or in combination must be completed before altering
the existing standard of care.
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